Publicaciones en colaboración con investigadores/as de Hospital Universitario Araba (67)

2024

  1. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

    Scientific Reports, Vol. 14, Núm. 1

  2. Comprehensive study of mechanical power in controlled mechanical ventilation: Prevalence of elevated mechanical power and component analysis

    Medicina Intensiva, Vol. 48, Núm. 3, pp. 155-164

  3. Does selective digestive decontamination (SDD) increase antibiotic resistance? Long-term comparison of two intensive care units (with and without SDD) of the same tertiary hospital

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 5, pp. 885-893

  4. Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach

    Antibiotics, Vol. 13, Núm. 6

  5. The pupillary dilation reflex to a nociceptive stimulus as a tool for analgesia management: A diagnostic study

    Australian Critical Care, Vol. 37, Núm. 2, pp. 230-235

2023

  1. Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study

    Blood Purification, Vol. 52, Núm. 5, pp. 464-473

  2. Post-intensive care syndrome at one month after hospital discharge in critically ill patients surviving COVID-19

    Medicina Intensiva, Vol. 47, Núm. 9, pp. 493-500

  3. Pupillary dilation reflex and behavioural pain scale: Study of diagnostic test

    Intensive and Critical Care Nursing, Vol. 74

2022

  1. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

    Scientific Data, Vol. 9, Núm. 1

  2. Inferior vena cava obstruction due to complete thrombosis of the filtering device

    Medicina Intensiva, Vol. 46, Núm. 9, pp. 542-543

  3. Kidney Support in Sepsis

    The Sepsis Codex (Elsevier), pp. 169-176

  4. Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study

    Journal of Intensive Care, Vol. 10, Núm. 1

  5. Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units

    Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89

2021

  1. Delayed alert to rapid response systems: proposal of a new quality indicator

    Medicina Intensiva, Vol. 45, Núm. 9, pp. e50-e52

  2. High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: A matter of time?

    Journal of Infection

  3. Platelet lysate nebulization protocol for the treatment of covid‐19 and its sequels: Proof of concept and scientific rationale

    International Journal of Molecular Sciences, Vol. 22, Núm. 4, pp. 1-18

  4. Population pharmacokinetics of levetiracetam and dosing evaluation in critically ill patients with normal or augmented renal function

    Pharmaceutics, Vol. 13, Núm. 10

  5. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study

    The Lancet Respiratory Medicine, Vol. 9, Núm. 3, pp. 239-250

  6. Pseudomonas aeruginosa susceptibility in spain: Antimicrobial activity and resistance suppression evaluation by pk/pd analysis

    Pharmaceutics, Vol. 13, Núm. 11

  7. Quantification of ceftaroline in human plasma using high‐performance liquid chromatography with ultraviolet detection: Application to pharmacokinetic studies

    Pharmaceutics, Vol. 13, Núm. 7